Global HIV Diagnostics Market Research Report, by Product (Consumables, Instruments and Software & Services), Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis and Tests for Viral Identification), End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Other) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027
Market Highlights
According to MRFR analysis, the Global HIV Diagnostics Market is expected to register a CAGR of 10.6% during the forecast period of 2020 to 2027 and is anticipated to reach USD 7,118.26 Million by 2027.
The growth of the global HIV diagnostics market is driven by various factors, such as the growing demand for the technologically advanced devices for diagnosing HIV with high accuracy, increasing adaption of home diagnostic kits for testing of HIV, rising funding for research and development activities to develop new kits. Additionally, the increasing strategic collaboration, expansion, and product launches by the companies also contributes in the market growth. On June 2018, Abbott announced the launch of a new point-of-care test called m-PIMA HIV-1/2 VL in the Netherlands for the easy, quick, and accurate management of HIV infection. However, the ignorance of healthcare issues, lack of awareness about the disease and limited availability of advanced products in the developing countries hamper the market growth.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The HIV diagnostics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The Americas is expected to be the largest market owing to the presence of large number of companies providing HIV diagnostics such as Bio-Rad Laboratorie, Becton, Dickinson & Company, Thermo-Fisher Scientific Inc., Abbott Laboratories and many more. Additionally, the rising cases of HIV contributes to grow the HIV diagnostics market in this region. For instance, in 2017 around 38,700 new HIV infection cases were reported in the US. The large number of HIV cases and presence of number of manufacturing companies drives the market growth in this region.
The European HIV diagnostics market is the second largest market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The increasing R&D to develop novel diagnostic kit, and growing funding for developing diagnostic kits boosts the market growth. The European Community supports the research activity by providing sufficient funding. The European Community has funded around USD 7.6 million in 2017 to develop the innovative tools to help end the epidemic.
The HIV diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. In Asia-Pacific region it was estimated that 5.9 million people living with HIV in 2018 in which India, China and Indonesia accounted for almost three-quarters of the total number of populations living with HIV in the region. The increasing awareness programs and presence of organizations such as National AIDS Control Organization (NACO), The Joint United Nations Programme on HIV and AIDS (UNAIDS) , and many more increases the awareness about the diagnosis and treatment methods drives the market growth in this region.
The HIV diagnostics market in the Middle East & Africa has been divided into the Middle East and Africa. The growing number of research laboratories in this region drives the market growth. In Southern Africa, currently around 2.1 million people were represented to be newly infected with HIV, out of which 240,000 are children. However the increasing healthcare infrastructure and presence of diagnostic centers in this region drives the market growth.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/9757
Segmentation
Global HIV Diagnostics Market has been segmented based on Product, Test Type, and End Users.
Global HIV Diagnostics Market has been segmented, on the basis on product, into consumables, instruments and software & services. Consumables segments covers products such as assays and kits & reagents and others. The instrument segment is expected to hold the maximum share of the market throughout the forecast period. The consumables segment is expected to be the fastest growing during the assessment period.
On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 tests and tests for early infant diagnosis. The antibody tests include HIV-1 screening test, HIV-1 antibody confirmatory tests and HIV-2 & group O diagnostic tests. The HIV-1 screening test is sub segmented into Elisa, rapid tests and home access dried blood spots. The HIV-1 antibody confirmatory tests are sub segmented into western blot test, indirect immunofluorescence assays (IFA), line immunoassays, and radio-immunoprecipitation assays.
On the basis of end-user, the market is segmented into diagnostic laboratories, hospitals, blood banks and others.
Key Players
Some of the key players in the global HIV diagnostics market are Siemens Healthineers (A Division of Siemens AG) (Erlangen, Germany), Roche Diagnostics (Division of Hoffman La Roche Ltd.) (Basel, Switzerland), Abbott Laboratories (Chicago, US), Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) (California, US), Thermo-Fisher Scientific Inc. (Massachusetts, US), Merck KGaA (Darmstadt, Germany), Becton, Dickinson & Company (New Jersey, US), Hologic Inc. (Massachusetts, US), Alere Inc. (Massachusetts, US), Bio-Rad Laboratorie (California, US) and many more.
Table Of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global HIV Diagnostics Market, By Product
1.1.2. Global HIV Diagnostics Market, By Test Type
1.1.3. Global HIV Diagnostics Market, By End User
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope Of The Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Breakdown Of Primary Respondents
3.5. Forecasting Test Types
3.6. Research Methodology For Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power Of Suppliers
5.1.2. Bargaining Power Of Buyers
5.1.3. Threat Of New Entrants
5.1.4. Threat Of Substitutes
5.1.5. Intensity Of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D And Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
5.3. Impact Of COVID 19 On HIV Diagnostics Market
5.3.1. Impact On Market Value In 2020 And 2021
5.3.2. Clinical Trial Impact
5.3.3. Impact Of Demand
5.3.4. Strategies To Overcome The Challenges
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/hiv-diagnostics-market-9757
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Related Report:
- Facial Injectors Market Research Report - Global Forecast till 2023
- Gel Documentation Systems Market Research Report - Global Forecast till 2023
- Cannula Market Research Report - Global Forecast till 2023
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
HIV Drugs Market:WiseGuyReports.com adds “Global HIV Drugs Market Research Report 2020-30” reports to its database.Executive SummaryThe global HIV drugs market is expected to grow from $27 billion in 2019 to about $30.5 billion in 2020 due to an increase in demand for such drugs for the treatment of Covid-19 patients.
Currently, several countries are evaluating and using antiretroviral drugs (for instance lopinavir boosted with ritonavir (LPV/r)), for treating corona virus infection.The HIV drugs market consists of sales of Human Immunodeficiency Virus (HIV) drugs used for the treatment of HIV infection/AIDS.
The market consists of revenue generated by the antiretroviral drug companies manufacturing the anti-retroviral drugs such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, integrase inhibitors, and protease inhibitors (PIs) for the treatment of HIV infection.Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5226499-hiv-drugs-global-market-report-2020-30-covidNorth America was the largest region in the HIV drugs market in 2019.Side Effects of HIV Drugs have always been a major challenge in antiretroviral therapy.
Antiretroviral drugs are used to treat HIV and AIDS as these drugs help lower viral load, control the growth of the virus, boosts the ability to fight infections, prevent HIV transmission to others and help stop or slow down symptoms.
There are several side effects associated with the therapy, thus impacting the growth of the market.Antiretroviral drugs market are increasingly implementing multi-class combination products for treatment of anti-retroviral therapy.
Example for multiclass combination drugs or single-tablet regimens (STRs), include both NRTIs and NNRTIs: doravirine, lamivudine, and tenofovir disoproxil fumarate (Delstrigo).
